the physiological effects of visfatin on immune response and inflammatory impacts on nephropathy

Obesity triggers the development of adipokines such as leptin, resistin, and visfatin, which have been associated with the development of diabetic nephropathy and other vascular disorders. the main purpose of the currentinvestigation was to identify the physiological impact of visfatin on immunological response and its inflammatory effects on nephropathy. fifty iraqi patients with chronic kidney disease (ckd) at various stages, as described by the national kidney foundation (nkf) and ranging in age from 48.367.56 to 53.68 8.46 years on average were considered. prior to the start of the investigation, informed consent was obtained from all participants, and the ethics committee approved the study. patients were classified into two groups: group (a) comprised patients with a gfr higher than 60 ml/minute, and group (b) comprised patients with a gfr of less than 60 ml/min. there was no considerable variance between the groups as regards visfatin, but a highly significant correlation between serum visfatin and crp was observed. the results of the current investigation indicated that serum visfatin levels are significantly correlated with crp in ckd patients; it is also correlated with deterioration of kidney function. moreover, higher visfatin levels were accompanied by increased serum triglyceride and cholesterol levels. these findings would suggest that visfatin may perform an essential function in uremia-related inflammation and may serve as a potential target for treatment and prevention of renal associated complications. future studies may delineate whether visfatin is a marker of disease activity and severity as well as a predictor of outcome in ckd.